JNJ Dividend Streak Continues as Company Posts Strong Financials

Johnson & Johnson has been paying dividends for an astonishing 64 consecutive years. The company's latest payout was $1.34 per share on June 9, 2026, with another identical payment scheduled for September 8, 2026.

The dividend growth streak is impressive, but the real story behind it is what keeps it alive despite challenges in one of its biggest drugs facing a competitive hit. JNJ's Innovative Medicine segment grew 6.8% operationally, driven by strong performances from DARZALEX and TREMFYA, among others.

The company's balance sheet remains healthy, with $20.42 billion in cash and $49.04 billion in total debt. CFO Joe Wolk emphasized the company's commitment to returning capital directly to shareholders through its dividend program.